We are live on
!
Find out more
GQG Partners Portfolio holdings
AUM
$53.8B
1-Year Est. Return
19.23%
This Fund
S&P 500
This Quarter
Est. Return
+13.67%
1 Year Est. Return
+19.23%
3 Year Est. Return
+225.42%
5 Year Est. Return
+476.53%
10 Year Est. Return
–
AUM
$8.06B
AUM Growth
+$1.57B
(+24%)
Cap. Flow
+$790M
Cap. Flow
% of AUM
9.8%
Top 10 Holdings %
Top 10 Hldgs %
56.54%
Holding
54
New
6
Increased
27
Reduced
5
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ServiceNow
NOW
|
+$177M |
| 2 |
Merck
MRK
|
+$126M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$95.1M |
| 4 |
Intuitive Surgical
ISRG
|
+$93.8M |
| 5 |
Procter & Gamble
PG
|
+$93.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$145M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$106M |
| 3 |
KT
KT
|
+$86.1M |
| 4 |
Vale
VALE
|
+$80M |
| 5 |
Coca-Cola
KO
|
+$78.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.71% |
| 2 | Healthcare | 24.93% |
| 3 | Technology | 22.52% |
| 4 | Utilities | 11.06% |
| 5 | Consumer Staples | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
UGI
UGI
$8.2B
| – | – |
-6,793
| Closed | -$362K |
|
|
52
Vale
VALE
$65.2B
| – | – |
-6,067,790
| Closed | -$80M |
|
|
RDS.A
53
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| – | – |
-3,883
| Closed | -$226K |
|
|
CHL
54
DELISTED
China Mobile Limited
CHL
| – | – |
-33,821
| Closed | -$1.63M |
|
Similar funds
HF
GQG Partners's Q1 2019 Portfolio in Review
As of Q1 2019, GQG Partners held 54 positions worth $8.06B, up 24% from $6.49B the previous quarter. Its ten largest holdings account for 57% of the portfolio.
GQG Partners deployed $790M of net new capital in Q1 2019, opening 6 new positions and adding to 27 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 514,859 shares worth $94.4M.
By sector, the portfolio is most concentrated in Financials at 28% of assets, down from 31% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $145M trimmed.
- GQG Partners's largest Q1 2019 buy was Vertex Pharmaceuticals: 514,859 shares worth $94.4M.
- GQG Partners added most to ServiceNow in Q1 2019, an estimated $177M increase.
- GQG Partners's biggest Q1 2019 reduction was Alphabet (Google) Class C, cutting an estimated $145M.
- GQG Partners fully exited Berkshire Hathaway Class B in Q1 2019, selling an estimated $106M.
- GQG Partners's ten largest holdings make up 57% of its $8.06B portfolio in Q1 2019.
- GQG Partners opened 6 new positions and closed 15 in Q1 2019.
- GQG Partners's portfolio value rose 24% quarter-over-quarter to $8.06B.
Based on GQG Partners's 13F filing for Q1 2019, filed 14 May 2019.